Correlation between time to progression and overall survival in patients with metastatic breast cancer

被引：1
|
作者：
Sherrill, B.
Hirst, C.
Wu, Y.
Amonkar, M. M.
Stein, S.
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] RTI Hlth Solut, Manchester, Lancs, England
[3] GlaxoSmithKline Inc, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68914-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A123 / A124
页数：2
相关论文
共 50 条
  • [31] ANALYSIS OF THE CORRELATION OF TIME TO TREATMENT FAILURE WITH OVERALL SURVIVAL VERSUS CORRELATION OF PROGRESSION-FREE SURVIVAL WITH OVERALL SURVIVAL
    Gibson, G. D.
    Henegan, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 548 - 548
  • [32] Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients
    Axel Muendlein
    Christine Heinzle
    Eva Maria Brandtner
    Andreas Leiherer
    Kathrin Geiger
    Stella Gaenger
    Heinz Drexel
    Tobias Dechow
    Thomas Decker
    Breast Cancer Research and Treatment, 2023, 201 : 571 - 576
  • [33] Impact of body mass index on overall survival in patients with metastatic breast cancer
    Saleh, Khalil
    Carton, Matthieu
    Dieras, Veronique
    Heudel, Pierre-Etienne
    Brain, Etienne
    D'Hondt, Veronique
    Mailliez, Audrey
    Patsouris, Anne
    Mouret-Reynier, Marie-Ange
    Goncalves, Anthony
    Ferrero, Jean Marc
    Petit, Thierry
    Emile, George
    Uwer, Lionel
    Debled, Marc
    Dalenc, Florence
    Jouannaud, Christelle
    Ladoire, Sylvain
    Leheurteur, Marianne
    Cottu, Paul
    Veron, Lucie
    Savignoni, Alexia
    Courtinard, Coralie
    Robain, Mathieu
    Delaloge, Suzette
    Deluche, Elise
    BREAST, 2021, 55 : 16 - 24
  • [34] Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients
    Muendlein, Axel
    Heinzle, Christine
    Brandtner, Eva Maria
    Leiherer, Andreas
    Geiger, Kathrin
    Gaenger, Stella
    Drexel, Heinz
    Dechow, Tobias
    Decker, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 571 - 576
  • [35] Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer
    Nemeth, Zsuzsanna
    Wijker, Wouter
    Lengyel, Zsolt
    Hitre, Erika
    Borbely, Katalin
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2683 - 2691
  • [36] Doubling time of progression-free survival by palbociclib in metastatic breast cancer
    L'Allemain, Gilles
    BULLETIN DU CANCER, 2015, 102 (04) : 300 - 300
  • [37] Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
    Gobbini, Elisa
    Ezzalfani, Monia
    Dieras, Veronique
    Bachelot, Thomas
    Brain, Etienne
    Debled, Marc
    Jacot, William
    Mouret-Reynier, Marie Ange
    Goncalves, Anthony
    Dalenc, Florence
    Patsouris, Anne
    Ferrero, Jean Marc
    Levy, Christelle
    Lorgis, Veronique
    Vanlemmens, Laurence
    Lefeuvre-Plesse, Claudia
    Mathoulin-Pelissier, Simone
    Petit, Thierry
    Uwer, Lionel
    Jouannaud, Christelle
    Leheurteur, Marianne
    Lacroix-Triki, Magali
    Cleaud, Audrey Lardy
    Robain, Mathieu
    Courtinard, Coralie
    Cailliot, Christian
    Perol, David
    Delaloge, Suzette
    EUROPEAN JOURNAL OF CANCER, 2018, 96 : 17 - 24
  • [38] NO RELEVANT INFLUENCE ON OVERALL SURVIVAL-TIME IN PATIENTS WITH METASTATIC BREAST-CANCER UNDERGOING COMBINATION CHEMOTHERAPY
    PETRU, E
    SCHMAHL, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (02) : 183 - 185
  • [39] Association between Bisphosphonate Use in Metastatic Breast Cancer (MBC) and Overall Survival.
    Mathew, A.
    Mathew, I. E.
    Rosenzweig, M. Q.
    Brufsky, A. M.
    CANCER RESEARCH, 2011, 71
  • [40] CORRELATIONS BETWEEN SURROGATE END POINTS AND OVERALL SURVIVAL IN ADVANCED OR METASTATIC BREAST CANCER
    Abdel-Kader, L.
    Castillo, M. A.
    Lacalle, J. R.
    Flores, S.
    VALUE IN HEALTH, 2011, 14 (07) : A436 - A436
12345